_version_ 1783594258115067904
author Corre, Jill
Montes, Lydia
Martin, Elodie
Perrot, Aurore
Caillot, Denis
Leleu, Xavier
Belhadj, Karim
Facon, Thierry
Hulin, Cyrille
Mohty, Mohamad
Fontan, Jean
Macro, Margaret
Brechignac, Sabine
Jaccard, Arnaud
Stoppa, Anne-Marie
Orsini-Piocelle, Frederique
Adiko, Didier
Voillat, Laurent
Keddar, Faiza
Barry, Marly
Demarquette, Helene
Certain, Marie-Noelle
Plantier, Isabelle
Roussel, Murielle
Hébraud, Benjamin
Filleron, Thomas
Attal, Michel
Avet-Loiseau, Hervé
author_facet Corre, Jill
Montes, Lydia
Martin, Elodie
Perrot, Aurore
Caillot, Denis
Leleu, Xavier
Belhadj, Karim
Facon, Thierry
Hulin, Cyrille
Mohty, Mohamad
Fontan, Jean
Macro, Margaret
Brechignac, Sabine
Jaccard, Arnaud
Stoppa, Anne-Marie
Orsini-Piocelle, Frederique
Adiko, Didier
Voillat, Laurent
Keddar, Faiza
Barry, Marly
Demarquette, Helene
Certain, Marie-Noelle
Plantier, Isabelle
Roussel, Murielle
Hébraud, Benjamin
Filleron, Thomas
Attal, Michel
Avet-Loiseau, Hervé
author_sort Corre, Jill
collection PubMed
description
format Online
Article
Text
id pubmed-7556617
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-75566172020-10-15 Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk Corre, Jill Montes, Lydia Martin, Elodie Perrot, Aurore Caillot, Denis Leleu, Xavier Belhadj, Karim Facon, Thierry Hulin, Cyrille Mohty, Mohamad Fontan, Jean Macro, Margaret Brechignac, Sabine Jaccard, Arnaud Stoppa, Anne-Marie Orsini-Piocelle, Frederique Adiko, Didier Voillat, Laurent Keddar, Faiza Barry, Marly Demarquette, Helene Certain, Marie-Noelle Plantier, Isabelle Roussel, Murielle Hébraud, Benjamin Filleron, Thomas Attal, Michel Avet-Loiseau, Hervé Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-09-01 /pmc/articles/PMC7556617/ /pubmed/33054068 http://dx.doi.org/10.3324/haematol.2019.236588 Text en Copyright© 2020 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Corre, Jill
Montes, Lydia
Martin, Elodie
Perrot, Aurore
Caillot, Denis
Leleu, Xavier
Belhadj, Karim
Facon, Thierry
Hulin, Cyrille
Mohty, Mohamad
Fontan, Jean
Macro, Margaret
Brechignac, Sabine
Jaccard, Arnaud
Stoppa, Anne-Marie
Orsini-Piocelle, Frederique
Adiko, Didier
Voillat, Laurent
Keddar, Faiza
Barry, Marly
Demarquette, Helene
Certain, Marie-Noelle
Plantier, Isabelle
Roussel, Murielle
Hébraud, Benjamin
Filleron, Thomas
Attal, Michel
Avet-Loiseau, Hervé
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
title Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
title_full Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
title_fullStr Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
title_full_unstemmed Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
title_short Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
title_sort early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556617/
https://www.ncbi.nlm.nih.gov/pubmed/33054068
http://dx.doi.org/10.3324/haematol.2019.236588
work_keys_str_mv AT correjill earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT monteslydia earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT martinelodie earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT perrotaurore earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT caillotdenis earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT leleuxavier earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT belhadjkarim earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT faconthierry earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT hulincyrille earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT mohtymohamad earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT fontanjean earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT macromargaret earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT brechignacsabine earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT jaccardarnaud earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT stoppaannemarie earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT orsinipiocellefrederique earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT adikodidier earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT voillatlaurent earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT keddarfaiza earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT barrymarly earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT demarquettehelene earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT certainmarienoelle earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT plantierisabelle earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT rousselmurielle earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT hebraudbenjamin earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT filleronthomas earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT attalmichel earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk
AT avetloiseauherve earlyrelapseafterautologoustransplantformyelomaisassociatedwithpoorsurvivalregardlessofcytogeneticrisk